Lippa A - Search Results

1

Hydrochloride Salt of the GABAkine KRM-II-81.

Mian MY, Divović B, Sharmin D, Pandey KP, Golani LK, Tiruveedhula VVNPB, Cerne R, Smith JL, Ping X, Jin X, Imler GH, Deschamps JR, Lippa A, Cook JM, Savić MM, Rowlett J, Witkin JM. Mian MY, et al. Among authors: lippa a. ACS Omega. 2022 Jul 27;7(31):27550-27559. doi: 10.1021/acsomega.2c03029. eCollection 2022 Aug 9. ACS Omega. 2022. PMID: 35967038 Free PMC article.

2

Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81.

Golani LK, Divović B, Sharmin D, Pandey KP, Mian MY, Cerne R, Zahn NM, Meyer MJ, Tiruveedhula VVNPB, Smith JL, Ping X, Jin X, Lippa A, Schkeryantz JM, Arnold LA, Cook JM, Savić MM, Witkin JM. Golani LK, et al. Among authors: lippa a. Biopharm Drug Dispos. 2022 Apr;43(2):66-75. doi: 10.1002/bdd.2313. Epub 2022 Mar 10. Biopharm Drug Dispos. 2022. PMID: 35194800

3

Can GABAkines quiet the noise? The GABA_A receptor neurobiology and pharmacology of tinnitus.

Witkin JM, Lippa A, Smith JL, Cook JM, Cerne R. Witkin JM, et al. Among authors: lippa a. Biochem Pharmacol. 2022 Jul;201:115067. doi: 10.1016/j.bcp.2022.115067. Epub 2022 Apr 30. Biochem Pharmacol. 2022. PMID: 35504315 Review.

4

GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA_A receptors.

Cerne R, Lippa A, Poe MM, Smith JL, Jin X, Ping X, Golani LK, Cook JM, Witkin JM. Cerne R, et al. Among authors: lippa a. Pharmacol Ther. 2022 Jun;234:108035. doi: 10.1016/j.pharmthera.2021.108035. Epub 2021 Nov 16. Pharmacol Ther. 2022. PMID: 34793859 Free PMC article. Review.

5

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.

Witkin JM, Lippa A, Smith JL, Jin X, Ping X, Biggerstaff A, Kivell BM, Knutson DE, Sharmin D, Pandey KP, Mian MY, Cook JM, Cerne R. Witkin JM, et al. Among authors: lippa a. Pharmacol Biochem Behav. 2022 Feb;213:173321. doi: 10.1016/j.pbb.2021.173321. Epub 2022 Jan 15. Pharmacol Biochem Behav. 2022. PMID: 35041859 Review.

6

Brain Vacuolation Resulting From Administration of the Type II Ampakine CX717 Is An Artifact Related to Molecular Structure and Chemical Reaction With Tissue Fixative Agents.

Purcell R, Lynch G, Gall C, Johnson S, Sheng Z, Stephen MR, Cook J, Garman RH, Jortner B, Bolon B, Radin D, Lippa A. Purcell R, et al. Among authors: lippa a. Toxicol Sci. 2018 Apr 1;162(2):383-395. doi: 10.1093/toxsci/kfx277. Toxicol Sci. 2018. PMID: 29253237

7

Oncolytic Properties of Ampakines In Vitro.

Radin DP, Purcell R, Lippa AS. Radin DP, et al. Anticancer Res. 2018 Jan;38(1):265-269. doi: 10.21873/anticanres.12217. Anticancer Res. 2018. PMID: 29277782

8

Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain.

Radin DP, Johnson S, Purcell R, Lippa AS. Radin DP, et al. Biomed Pharmacother. 2018 Sep;105:540-544. doi: 10.1016/j.biopha.2018.06.008. Epub 2018 Jun 7. Biomed Pharmacother. 2018. PMID: 29886374

9

Acute ampakine treatment ameliorates age-related deficits in long-term potentiation.

Radin DP, Zhong S, Purcell R, Lippa A. Radin DP, et al. Among authors: lippa a. Biomed Pharmacother. 2016 Dec;84:806-809. doi: 10.1016/j.biopha.2016.10.016. Epub 2016 Oct 7. Biomed Pharmacother. 2016. PMID: 27721179

10

Stargazin differentially modulates ampakine gating kinetics and pharmacology.

Radin DP, Li YX, Rogers G, Purcell R, Lippa A. Radin DP, et al. Among authors: lippa a. Biochem Pharmacol. 2018 Feb;148:308-314. doi: 10.1016/j.bcp.2018.01.019. Epub 2018 Jan 9. Biochem Pharmacol. 2018. PMID: 29330065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page